Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled study

By Poyurovsky M.   Koren D.   Gonopolsky I.   Schneidman M.   Fuchs C.   Weizman A.   Weizman R.  

European Neuropsychopharmacology, Vol. 13, Iss. 2, 2003-03 ,pp. : 123-128

Elsevier

Access to resources Recommend Favorite

The Role of Baseline Blood Pressure in Guiding Treatment Choice: A Secondary Analysis of the Use of Valsartan/Hydrochlorothiazide as Initial Therapy in Hypertensive Adults in a Randomized, Double-Blind, Placebo-Controlled Trial

By Pool James L.  

Clinical Drug Investigation, Vol. 29, Iss. 12, 2009-12 ,pp. : 791-802

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Nebulized Formoterol as Add-on Therapy in COPD Patients Receiving Maintenance Tiotropium Bromide: Results from a 6-Week, Randomized, Placebo-Controlled, Clinical Trial

By Hanania Nicola A.  

Drugs, Vol. 69, Iss. 9, 2009-06 ,pp. : 1205-1216

Adis International

Access to resources Recommend Favorite

Safety of the Combination of Intensive Cholesterol-Lowering Therapy with Oral Anticoagulation Medication in Elderly Patients with Atrial Fibrillation: A Randomized, Double-Blind, Placebo-Controlled Study

By Enajat Morteza  

Drugs & Aging, Vol. 26, Iss. 7, 2009-07 ,pp. : 585-593

Adis International

Access to resources Recommend Favorite

Efficacy of Rebamipide as Adjunctive Therapy in the Treatment of Recurrent Oral Aphthous Ulcers in Patients with Behçet's Disease: A Randomised, Double-Blind, Placebo-Controlled Study

By Matsuda T.  

Drugs in R&D, Vol. 4, Iss. 1, 2003-01 ,pp. : 19-28

Adis International

Access to resources Recommend Favorite